Art

J-GLOBAL ID：201902225808743497   Reference number：19A2351529

Characteristics and outcomes of children with acute myeloid leukemia and Down syndrome who are ineligible for clinical trials due to severe comorbidities

重症共存症による臨床試験のために無効な急性骨髄性白血病とダウン症候群の小児の特徴と転帰【JST・京大機械翻訳】

Author (18)： Nakashima Kentaro (Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan) ,  Nakashima Kentaro (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Hasegawa Daisuke (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Hasegawa Daisuke (Department of Pediatrics, St. Luke’s International Hospital, Tokyo, Japan) ,  Tomizawa Daisuke (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Tomizawa Daisuke (Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan) ,  Miyamura Takako (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Miyamura Takako (Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan) ,  Hama Asahito (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Hama Asahito (Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan) ,  Iwamoto Shotaro (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Iwamoto Shotaro (Department of Pediatrics, Mie University School of Medicine, Mie, Japan) ,  Terui Kiminori (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Terui Kiminori (Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan) ,  Adachi Souichi (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Adachi Souichi (Department of Human Health Sciences, Kyoto University, Kyoto, Japan) ,  Taga Takashi (AML Committee, Japan Children’s Cancer Group, Nagoya, Japan) ,  Taga Takashi (Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan)
Material： Pediatric Blood & Cancer
Volume： 66  Issue： 11  Page： e27942  Publication year： 2019 
JST Material Number： W2716A  ISSN： 1545-5009  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： BACKGROUND: High survival rate...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2351529&from=J-GLOBAL&jstjournalNo=W2716A") }}

Thesaurus term： human ,  *acute myeloid leukemia ,  *Down Syndrome ,  drug therapy ,  remission ,  man ,  *clinical trial ,  survival ratio ,  *child ,  complication ,  optimal dosage ,  5 years survival rate ,  *comorbidities ,  nitrogen heterocyclic compound ,  pyrimidine nucleoside ,  urea compound ,  furanoside
Semi thesaurus term： 5年全生存率 ,  完全寛解 ,  *転帰 ,  *共存罹患 , 【Automatic Indexing@JST】

Author keywords (5)： acute myeloid leukemia ,  clinical trial ,  comorbidity ,  congenital heart disease ,  Down syndrome

JST classification (1)： Blood cell tumors(=neoplasms)  (GK04000M)

Substance index (1)： Cytarabine

Terms in the title (7)： 重症 ,  共存症 ,  臨床試験 ,  急性骨髄性白血病 ,  ダウン症候群 ,  小児 ,  転帰